CION Investment Corporation CION posts narrow Q4 2025 EPS beat steep annual revenue drop pulls shares 092 percent lower Theriva Biologics TOVX Comprehensive Review Theriva Biologics posts 346 EPS beat no revenue Chiron XRN Resistance Levels Q4 2025 EPS Misses Views DHCNL Diversified Healthcare Trust 625 Senior Notes Due 2046 reports narrower Q4 2025 per share loss that outperforms analyst estimates Potential Tariff Reductions on the Horizon US Trade Representative Signals Kazatomprom Posts 17 Production Jump in Q3 Boosting Uranium Supply Outlook HDFC Banks Fundamentals Remain Solid Amid Stock Weakness EU Industry Commissioner Warns Against SingleCountry Supply Chain Reliance Amid China Tensions Ripple XRP Price Outlook Could the Token Reach 15 by 2027 European Shares Climb to OneMonth High on Tech Rally and Geopolitical Optimism Free Fish Fillet Program Offers Lifeline to Maines Groundfishing Industry Amid Rising Costs